Antitumor compositions and methods of treatment
AssigneeEli Lilly and Company
InventorJ. Jeffry Howbert
Life of this patent
Estimating the term…
Abstract
A method is provided for treating a susceptible neoplasm in mammals which comprises administering to a mammal in need of said treatment an effective amount for treating the neoplasm of the compound N-[[(4-chlorophenyl)amino]carbonyl]-1-butanesulfonamide or a pharmaceutically acceptable salt thereof, wherein said neoplasm is selected from the group consisting of ovarian, non-small cell lung, gastric, pancreatic, renal cell, breast, colorectal, small-cell lung, melanoma, head and neck, Kaposi's sarcoma, and rhabdomyosarcoma.
Claims1
A method of treating a susceptible neoplasm in mammals which comprises administering to a mammal in need of said treatment an effective amount of treating the neoplasm of the compound N-1-butanesulfonamide or a pharmaceutically salt thereof wherein said neoplasm is selected from the group consisting of ovarian, non-small cell lung, gastric, pancreatic, renal cell, breast, colorectal, small-cell lung, melanoma, head and neck, Kaposi's sarcoma, and rhabdomyosarcoma.
Dependencies are inferred from the claim text.